VTRS Q3 2018 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

Q3 2018 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.9B-4.2% YoY

Gross Profit

$1.0B36.3% margin

Operating Income

$338M11.8% margin

Net Income

$177M6.2% margin

EPS (Diluted)

$0.34

QoQ Revenue Growth

+1.9%

Cash Flow

Operating Cash Flow

$654M

Free Cash Flow

$592M

Stock-Based Comp.

-$27M

Balance Sheet

Total Assets

$33.5B

Total Liabilities

$21.4B

Stockholders' Equity

$12.1B

Cash & Equivalents

$449M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.9B	$3.0B	-4.2%
Gross Profit	$1.0B	$1.2B	-11.8%
Operating Income	$338M	$317M	+6.9%
Net Income	$177M	$88M	+100.1%